Additional research has supported this conclusion, as Small et al. analyzed data from three different cohorts, showing that higher Lp(a) levels were linked to PAD, independent of inflammation levels in both primary and secondary prevention populations [135]. The gene discussed is LPA; the disease is peripheral arterial disease.